John P. Leonard, MD | Authors


Addressing Treatment Gaps in Follicular Lymphoma

March 17, 2021

Dr John P. Leonard highlights ongoing clinical trials and therapies of interest in the follicular lymphoma pipeline and explains how progress in the field will help address ongoing treatment challenges.

PI3K Inhibitors for Relapsed/Refractory FL: Safety & Efficacy

March 17, 2021

John P. Leonard, MD, of Weill Cornell Medicine and NewYork-Presbyterian Hospital, comments on the safety and efficacy data for PI3K inhibitors for relapsed/refractory follicular lymphoma treatment and shares advice on best practices for monitoring patients on therapy and managing any treatment-related adverse events.